Skip to content

Clinical trials

Anemia, Hemolytic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Hemolytic Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20062
20081
20091
20101
20111
20131
20141
20151
20162
20183
20203
20214
20223
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting5
Active, not recruiting3
Terminated3
Not yet recruiting2
Enrolling by invitation1
Withdrawn1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Agios Pharmaceuticals, Inc.4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Editas Medicine, Inc.2
Forma Therapeutics, Inc.2
National Heart, Lung, and Blood Institute (NHLBI)2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Apellis Pharmaceuticals, Inc.1
Archemix Corp.1
Boston Children's Hospital1
Children's Hospital Medical Center, Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Hemolytic35
Anemia, Sickle Cell13
Anemia12
Hematologic Diseases8
Hemoglobinopathies6
Hemolysis6
Genetic Diseases, Inborn5
Fibrosis4
Hepatitis C4
Anemia, Hemolytic, Congenital3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.